Potential Game-Changer
We are bringing annuloplasty to the structural heart field using a familiar catheter-based procedure.
Market Expansion
CathHELIX™ has the potential to be a first-line therapy, expanding the treatable patient population.
HVR Cardio is uniquely positioned
HVR Cardio is a cardiovascular device company developing breakthrough solutions for mitral valve repair based on its proprietary HELIX technology. This new technology, using a minimally invasive procedure, provides a first-line treatment option for patients.
™
Our mission
​
To develop solutions for mitral valve interventions that are fast, easy to use, and less invasive while enhancing clinical efficacy.
Our goal
​
To provide structural interventionalists a first-line mitral valve repair option to treat the root cause of mitral valve regurgitation, annular dilation.
HVR Cardio is dedicated to expanding transcatheter mitral valve treatment choices by transforming the standard for surgical mitral valve repair into a transcatheter approach.
